Health
2nd study testing a COVID-19 antibody drug has a setback – Devdiscourse
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need…
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalised patients. Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need intense oxygen treatment or breathing machines — because of a potential safety problem and unfavourable balance of risks and benefits.
The study can continue to test the two-antibody…
-
General24 hours agoAustralia’s Myanmar community mourns earthquake losses
-
Noosa News23 hours agoAustralian growers expect to benefit from US tariffs as Trump’s trade war angers markets
-
Noosa News20 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News23 hours agoHow to get the most from potted citrus and when they’ll fruit